ACG 2025 | Stop Spinning Your Wheels on EoE

Drs. Dellon and Dickstein host a Symposium where audience members solve puzzles to uncover cutting-edge knowledge of eosinophilic esophagitis (EoE). This event is neither sponsored by nor endorsed by ACG.

MD, MPH

Evan Dellon +1 more

Learning objectives

Gain a deeper understanding on the pathophysiology of eosinophilic esophagitis (EoE) and the role of type 2 inflammation in disease progression
Discuss approaches to EoE diagnosis and long-term management in clinical practice

Description

At ACG 2025, Drs. Evan Dellon and George Dickstein hosted a game-show style experience where 2 teams earned points by completing phrases about real-world evidence, diagnostic tools, and comprehensive disease-management strategies. Join this captivating tour of EoE as team representatives take part in this educational experience and our hosts provide their expert knowledge!

About these experts

Gastroenterology

MD, MPH

Evan Dellon

Director of the Center for Esophageal Diseases and Swallowing, Professor of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine | Chapel Hill, North Carolina, United States

Gastroenterology

MD, FASGE, AGAF

George Dickstein

Associate Clinical Professor of Medicine and Academic Dean, Tufts University School of Medicine | Sr. VP of Clinical Affairs, Gastro Health | Framingham, Massachusetts, United States

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: JapanChange country/region